Stock-Based Compensation
$349.00M
TTM · Period ending: · USD
MRNA Stock-Based Compensation
Latest reported$349.00Mperiod ending
Latest reported$349.00Mperiod ending
MRNA Stock-Based Comp ($39.36M → $349.00M)
Annual stock-based compensation
High-resolution chart · PNG
MRNA stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 483,000,000 | |
| 429,000,000 | |
| 305,000,000 | |
| 226,000,000 | |
| 142,000,000 | |
| 93,000,000 | |
| 81,122,000 | |
| 72,565,000 | |
| 40,055,000 | |
| 39,360,000 |